CAESAREA, Israel, Nov. 20, 2017 /PRNewswire/ -- DarioHealth Corp.
(NASDAQ: DRIO), a leading global digital health company with mobile
health and big data solutions, today announced the availability of
update version 3.5 of its MyDario app. The app update includes
support for DarioHealth's new Lightning compatible device for
iPhone 7 and iPhone 8 which was recently awarded the CE Mark.
The DarioHealth lightning adapter is currently under
consideration for regulatory approval with the United States Food
and Drug Administration and the Therapeutic Goods Administration
(TGA) in Australia.
The 3.5 version update ensures that users will be able to
receive the same quality user experience with DarioHealth on the
latest Apple devices, including the brand-new iPhone 8.
Erez Raphael, Chairman and CEO of
DarioHealth, commented, "From a software perspective, we continue
to stay ahead of the technological change curve with
behind-the-scene adjustments that pave the way for consumers with
iPhone 7 and 8. On the product marketing side, we've worked with
our customers to understand their needs, and it is very gratifying
to launch a version that introduces several new features which
continue to simplify diabetes management."
Amongst the new features that are being rolled out with version
3.5 are a weight log and a barcode scanner. The weight log
seamlessly integrates with Dario's intuitive logbook and charts.
Now customers have one place where they can see their diabetes
snapshot and track their weight.
In addition, customers can now scan foods with the barcode
scanner feature in the all-in-one smart diabetes system. This
permits easier carb counting, as customers simply point their
smartphone at a barcode and the app imports the nutritional
information for the particular food. DarioHealth believes this
feature will increase customer engagement, and help customers keep
better track of their carbohydrate intake.
About DarioHealth Corp.
DarioHealth Corp. is a leading
global digital health company serving tens of thousands of users
with dynamic mobile health solutions. We believe people deserve the
best tools to manage their treatment, and harnessing big data, we
have developed a unique way for our users to analyze and
personalize their diabetes management. With our smart diabetes
solution, users have direct access to track and monitor all facets
of diabetes, without having the disease slow them down. The
acclaimed Dario™ Blood Glucose Monitoring System all-in-one blood
glucose meter and native smartphone app gives users an unrivaled
method for self-diabetes management. DarioHealth is headquartered
in Caesarea, Israel with a
regional office in Burlington,
Massachusetts. For more information, visit
http://mydario.investorroom.com/.
Cautionary Note Regarding Forward-Looking Statements
This news release and the statements of representatives and
partners of DarioHealth Corp. (the "Company") related thereto
contain or may contain forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995.
Statements that are not statements of historical fact may be deemed
to be forward-looking statements. Without limiting the generality
of the foregoing, words such as "plan," "project," "potential,"
"seek," "may," "will," "expect," "believe," "anticipate," "intend,"
"could," "estimate," or "continue" are intended to identify
forward-looking statements. For example, the Company is using
forward-looking statements in this press release when it describes
pending regulatory approvals for the Lightning adapter and the
benefits of the app version update. Readers are cautioned
that certain important factors may affect the Company's actual
results and could cause such results to differ materially from any
forward-looking statements that may be made in this news release.
Factors that may affect the Company's results include, but are not
limited to, regulatory approvals, product demand, market
acceptance, impact of competitive products and prices, product
development, commercialization or technological difficulties, the
success or failure of negotiations and trade, legal, social and
economic risks, and the risks associated with the adequacy of
existing cash resources. Additional factors that could cause or
contribute to differences between the Company's actual results and
forward-looking statements include, but are not limited to, those
risks discussed in the Company's filings with the U.S. Securities
and Exchange Commission. Readers are cautioned that actual results
(including, without limitation, the timing for and results of the
Company's commercial and regulatory plans for Dario™ as described
herein) may differ significantly from those set forth in the
forward-looking statements. The Company undertakes no obligation to
publicly update any forward-looking statements, whether as a result
of new information, future events or otherwise, except as required
by applicable law.
DarioHealth Corporate Contact:
Shmuel Herschberg
Marketing Director
shmuel@mydario.com
1-914-775-5548
DarioHealth Public Relations Contact:
Terese Kelly
Rosica PR
terese@rosica.com
1-201-843-5600
DarioHealth Investor Relations Contact:
Stephen Hart
Hayden IR,
DRIO@HaydenIR.com
1-917-658-7878
View original
content:http://www.prnewswire.com/news-releases/dariohealth-launches-version-35-of-its-mydario-app-to-support-iphone-7-and-iphone-8-300559244.html
SOURCE DarioHealth Corp.